|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 15 studies with search of: | Open Studies | "beta-Thalassemia" |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia Major
|
||||
| 2 | Recruiting |
Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia
|
||||
| 3 | Recruiting |
Genetic Factors Affecting the Severity of Beta Thalassemia
|
||||
| 4 | Recruiting |
Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients
|
||||
| 5 | Recruiting |
Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major
|
||||
| 6 | Recruiting |
Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload
|
||||
| 7 | Recruiting |
Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease and Beta-Thalassemia
|
||||
| 8 | Recruiting |
Stem Cell Transplant in Sickle Cell Disease and Thalassemia
|
||||
| 9 | Recruiting |
Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia
|
||||
| 10 | Recruiting |
Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 Msec
|
||||
| 11 | Recruiting |
Endocrine and Nutritional Assessment in B Thalassemia Major
|
||||
| 12 | Recruiting |
Interferon and Ribavirin Treatment in Patients With Hemoglobinopathies
|
||||
| 13 | Recruiting |
Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload
|
||||
| 14 | Recruiting |
Iron Overload and Growth Velocity in Thalassemia and Sickle Cell Anemia
|
||||
| 15 | Recruiting |
Phase II Randomized Trial of Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
|